In addition, a continuous increase in vaginal sexual arousal may result in higher genital sensations and sexual appetitive behaviors. There is a time lag effect when testosterone is administered, on genital arousal in women. Women's level of testosterone is higher when measured pre-intercourse vs. pre-cuddling, as well as post-intercourse vs. post-cuddling. Androgens may modulate the physiology of vaginal tissue and contribute to female genital sexual arousal. Men who watch a sexually explicit movie have an average increase of 35% in testosterone, peaking at 60–90 minutes after the end of the film, but no increase is seen in men who watch sexually neutral films. The rise in testosterone during competition predicted aggression in males, but not in females. Testosterone and other androgens have evolved to motivate men to pursue competition, even when doing so leads to risk. The first is the challenge hypothesis which states that testosterone would increase during puberty, thus facilitating reproductive and competitive behavior which would include aggression. The male generative glands also contain Sertoli cells, which require testosterone for spermatogenesis. Testosterone is also synthesized in far smaller total quantities in women by the adrenal glands, thecal cells of the ovaries, and, during pregnancy, by the placenta. Like other steroid hormones, testosterone is derived from cholesterol (Figure 1). In contrast to testosterone, DHEA and DHEA sulfate have been found to act as high-affinity agonists of these receptors. Greatly differing amounts of testosterone prenatally, at puberty, and throughout life account for a share of biological differences between males and females. The areas of binding are called hormone response elements (HREs), and influence transcriptional activity of certain genes, producing the androgen effects. Some people with DSDs that are raised as female may have sex chromosomes other than XX, or potentially also elevated testosterone levels, according to NIH. Finally, replication of the genetic scores was attempted with measurements of total testosterone (5,334 men and 3,804 women) and of SHBG (5,694 men and 5,476 women) from the EPIC Norfolk study34. In conclusion, our findings provide unique insights into the disease impacts of testosterone and highlight the importance of sex-specific analyses of disease risk. While we could distinguish a cluster-specific genetic instrument for testosterone that was independent of SHBG, the effects of this, and our other testosterone instruments, might be mediated at least in part by downstream conversion of testosterone to estradiol. First, we detected causality between higher T levels and several sex-biased phenotypes with biological links to T, but less contribution to most other phenotypes, echoing experimental data and findings from recent MR studies23,26. Taken together, supporting recent recommendations, our data suggests that the risks and benefits of using T as a medical treatment should be carefully weighted, given T’s complex and indirect relationship to most phenotypes and potential adverse and beneficial outcomes in both sexes7,26. Here, using genetic data is an alternative means to estimate how population variability in baseline T levels connects with human health, leading to causal insights beyond the reported epidemiological relationships. Since its discovery in the early 20th century, testosterone (T) has been proposed to modify phenotypes and diseases that differ between the sexes, due to the extensive male-female differences in circulating T levels. Finally, the cross-sex analyses implied increased androgen load as a direct contributor to poorer reproductive health in women. Given this, we reasoned that cross-sex analyses, i.e., analysis of the effect of a sex-specific PGS in the opposite sex, would provide a unique opportunity to assess if the original associations stem from T action, and to detect potential antagonistic effects for the PGSs between the sexes. Androgen receptors occur in many different vertebrate body system tissues, and both males and females respond similarly to similar levels. The part of the total hormone concentration that is not bound to its respective specific carrier protein is the free part. Specific proteins include sex hormone-binding globulin (SHBG), which binds testosterone, dihydrotestosterone, estradiol, and other sex steroids. Sex hormone binding globulin (SHBG) is a steroid hormone (e.g. testosterone) transport protein produced in the liver. Higher levels of SHBG mean less free testosterone is available, and lower levels of SHBG usually mean more active testosterone is available. In addition to turning on growth-related genes in the cell nucleus, testosterone also has non-genomic effects as a signaling molecule.ref Once bound to the receptor, the hormone can translocate into the nucleus of the cell and regulate gene transcription for specific androgen-sensitive genes.ref
